Skip to main content
Fig. 1 | AIDS Research and Therapy

Fig. 1

From: Renal function in Japanese HIV-1-positive patients who switch to tenofovir alafenamide fumarate after long-term tenofovir disoproxil fumarate: a single-center observational study

Fig. 1

A Changes in eGFR (mean ± SE) of the patients taking TAF after taking TDF for more than 48 weeks. B Change in eGFR (mean ± SE) in patients taking TAF classified by eGFR values after taking TDF for more than 48 weeks. eGFR estimated glomerular filtration rate, TDF tenofovir disoproxil fumarate, TAF tenofovir alafenamide fumarate, TDF0 start of TDF, TAF0 start of TAF; TAF12, -24, -48, -96 and -144: 12 weeks, 24 weeks, 48 weeks, 96 weeks and 144 weeks after starting TAF. *p < 0.05 is defined as significant differences by the paired t-test

Back to article page